Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Nausea 12Vomiting 11Neoplasms 7Hematologic Neoplasms 5Anorexia 4Cachexia 3Breast Neoplasms 3Weight Loss 2Stomach Neoplasms 2Advanced Cancer 2Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy 1Sedentary Behavior 1Prosthesis Failure 1Postoperative Nausea and Vomiting 1Pain 1Opioid-Related Disorders 1Nutrition Disorders 1Neoplasms, Plasma Cell 1Neoplasms, Germ Cell and Embryonal 1Muscular Atrophy 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Lung Neoplasms 1Insulin Resistance 1Hyperlipidemias 1Hyperglycemia 1Gynecologic Cancer 1Esophageal Neoplasms 1

Interventions

Surveys and Questionnaires 15Acupuncture Therapy 15Fentanyl 14Morphine 13Acetaminophen 13Analgesia 12Lidocaine 11Ketamine 11Bupivacaine 11Methadone 10Therapeutics 9Ropivacaine 9Psychiatric Rehabilitation 9Oxycodone 9Hydromorphone 7Saline Solution 6Radiotherapy 6Music Therapy 6Early Intervention, Educational 6Zoledronic Acid 5Yoga 5Water 5Methods 5Control Groups 5Transcutaneous Electric Nerve Stimulation 4Therapeutic Touch 4Physical Therapy Modalities 4Massage 4Ketorolac 4Exercise 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pain × Olanzapine × Clear all
NCT00737191 2012-03-09

Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain

Mayo Clinic

Phase NA Withdrawn
Other hematologic neoplasm

Pain, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡